Clinical Trial Update: This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response [Phase 2]

View source ↗

Summary

This clinical trial update outlines a two-cohort Phase 2 exploratory study evaluating benmelstobart alone or in combination with anlotinib before surgery. The a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart

Snippet

Sponsor: Tang-Du Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING